Addex Therapeutics (ADXN.SW) Announces Presentation of Dipraglurant Phase 2a Study Results at the 2013 Annual Meeting of the American Academy of Neurology
3/22/2013 8:50:49 AM
More...
|
Daval International Limited CSO Presents Results From an Exploratory Clinical Trial of AIMSPRO in Amyotrophic Lateral Sclerosis (ALS) at American Academy of Neurology Annual Meeting
3/21/2013 12:05:23 PM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Presentation of Data From Its Pivotal Phase III Parkinson's Disease Psychosis Study With Pimavanserin at the American Academy of Neurology Annual Meeting
3/21/2013 10:55:29 AM
More...
|
Data From Isis Pharmaceuticals, Inc. (ISIS)-SMN Rx Phase 1 Study in Children With Spinal Muscular Atrophy Presented at the American Academy of Neurology Meeting
3/21/2013 9:51:55 AM
More...
|
BioTie Therapies Corp. Presents Tozadenant Phase 2b Data at American Academy of Neurology Annual Meeting
3/21/2013 9:51:03 AM
More...
|
Orion Corporation Presented Promising Phase II Data for New Alzheimer's Disease Drug at American Academy of Neurology Annual Meeting
3/21/2013 9:49:18 AM
More...
|
Adamas Pharmaceuticals Presents New Traumatic Brain Injury Data From Its Nurelin™ Program at American Academy of Neurology Conference
3/20/2013 9:21:41 AM
More...
|
Chelsea Therapeutics, Inc. (CHTP) Announces Presentation of Northera™ (droxidopa) Study 306 Data at the American Academy of Neurology Annual Meeting
3/19/2013 11:05:06 AM
More...
|
Upsher-Smith Laboratories Presents Favorable Phase I Data for USL261, a Novel Formulation of Intranasal Midazolam, at 65th Annual Meeting of the American Academy of Neurology
3/19/2013 10:27:03 AM
More...
|
Impax Pharmaceuticals (IPXL) Announces Presentation of RYTARYTM (IPX066) (Carbidopa and Levodopa) Extended-Release Capsules Phase III and Open-Label Extension Data at the American Academy of Neurology 2013 Annual Meeting
3/19/2013 9:42:47 AM
More...
|
|